The patient stated his finger may have been squeezed excessively at the time of testing.The meter and test strips were provided for investigation where they were tested using retention controls.Vial #1 testing results (qc range = 2.3 - 3.5 inr): qc 1: 2.5 inr, qc 2: 2.5 inr, qc 3: 2.5 inr.Vial #2 testing results (qc range = 2.3 - 3.5 inr): qc 1: 2.5 inr, qc 2: 2.5 inr, qc 3: 2.5 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The results alleged by the customer were found in the meter¿s patient result memory with the time and date set incorrectly.Routine retention testing was performed and passed the internal inspection.Retention testing data is reviewed and appropriate actions are taken as needed.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." unique identifier (udi) #(b)(4).
|
There was an allegation of a questionable result from coaguchek xs meter serial number (b)(4).Around 8:06 am, the laboratory result using neoplastin reagent was 2.6 inr.Around 9:00-9:30 am, the meter result was 4.4 inr.The therapeutic range was 2.0-3.0 inr and the patient tests every two weeks.
|